Relapsed Refractory Osteosarcoma clinical trials

Explore recruiting relapsed refractory osteosarcoma clinical trials.

Recruiting relapsed refractory osteosarcoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Relapsed Refractory Osteosarcoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized phase II study comparing the safety and efficacy of mifamurtide and standard therapy containing sorafenib in pediatric and young adult patients with high-risk osteosarcoma

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Relapsed Refractory Osteosarcoma trials by city

Relapsed Refractory Osteosarcoma in Toronto Relapsed Refractory Osteosarcoma in Vancouver Relapsed Refractory Osteosarcoma in Montreal Relapsed Refractory Osteosarcoma in Calgary Relapsed Refractory Osteosarcoma in Edmonton Relapsed Refractory Osteosarcoma in Ottawa Relapsed Refractory Osteosarcoma in Winnipeg Relapsed Refractory Osteosarcoma in Quebec City Relapsed Refractory Osteosarcoma in Hamilton Relapsed Refractory Osteosarcoma in Kitchener Relapsed Refractory Osteosarcoma in London Relapsed Refractory Osteosarcoma in Halifax Relapsed Refractory Osteosarcoma in New York Relapsed Refractory Osteosarcoma in Los Angeles Relapsed Refractory Osteosarcoma in Chicago Relapsed Refractory Osteosarcoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease